Evolutionary algorithms and de novo peptide design

Soft Computing

Volumn 10, Issue 4, 2006, Pages 295-304

  Belda, I ^a   Llora X ^b   Giralt, E ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NONE   (Spain)

Author keywords

Evolutionary algorithms; Genetic algorithms; Ligand design; Peptide design; Surface patch

Indexed keywords

EID: 29544441437     PISSN: 14327643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00500-005-0487-7     Document Type: Article

References (52)

1. Ajay A, Walters WP, Murko MA (1998) Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J Med Chem 41(18):3314-3324
2. Apostolakis J, Caflish A (1999) Computational ligand design. Combi Chem High Throughput Screen 2:91-104
3. Back T (1997) Evolutionary algorithms in theory and practice. Oxford University Press, New York
4. Baluja S, Caruana R (1995) Removing the genetics from standard genetic algorithm. In: Prieditis A, Russell S (eds) Proceedings of the international conference on machine learning. Morgan Kaufmann, San Franisco, pp 112-128
5. Belda I, Llorà X, Martinell M, Tarragó T, Giralt E (2004) Computer-aided peptide evolution for virtual drug design. In: Deb K et al (ed) Genetic and evolutionary computation conference-GECCO 2004. Also availables as IlliGAL technical report, No. 2004015. Lecture Notes in Computer Science No. 3103, Springer, Berlin Heidelberg New York, pp 321-332
6. Belda I, Llorà X, Martinell M, Tarragó T, Piqueras M-G, Nicolás E, Giralt E Evolutionary algorithms and de novo peptide design. J Comput Aided Mol Des (to submitted)
7. Böhm HJ (1996) Computational tools for structure-based ligand design. Program Biophys Mol Biol 3:197-210
8. Böhm HJ (1998) Prediction of binding constants of protein ligands: a fast method for the priorization of hits obtained from de novo design or 3D database search programs. J Comput Aided Mol Des 12(4):309-323
9. Bohm HJ, Schneider G (ed) (2000) Virtual screening for bioactive molecules. Wiley, New York
10. Bolten BM, DeGregorio T (2002) Trends in development cycles. Nat Drug Discover 1:551-555
11. Budin N, Majeux N, Tenette C, Caflisch A (2001) Structure-based ligand design by a build-up approach and genetic algorithm search in conformational space. J Comput Chem 22(16):1956-1970
12. Chiva C, Barthe P, Codina A, Gairí M, Molina F, Granier C, Pugniere M, Inui T, Nishi H, Nishiuchi Y, Kimura T, Sakakibara S, Albericio F, Giralt E (2003) Synthesis and NMR structure of p41icf, a protein inhibitor of human cathepsin L. J Am Chem Soc 125(6):1508-1517
13. Codina A, Gairí M, Tarragó T, Vigueras AR, Feliz M, Ludevid D, Giralt E (2002) 1h(n), 15n, 13co, 13ca, 13b assignement and secondary structure of a 20 kda a-l-fucosidade from pea using TROSY. J Biomol NMR 22:295-296
14. Corey DR (1999) Design and engineering of proteins as therapeutic agents. In Wu-Pong S, Rojanasakul (ed) Biopharmaceutical Drug Design Development. Humana Press, Inc.:187-203
15. Davis L (1996) Handbook of genetic algorithms. International Thomson Computer Press
16. Deb K, Agrawal S, Pratab A, Meyarivan T (2000) A fast elitist non-dominated sorting genetic algorithm for multi-objective optimization: NSGA-II. In: Schoenauer M, Deb K, Rudolph G, Yao X, Lutton E, Merelo JJ, Schwefel H-P (eds) Proceedings of the parallel problem solving from nature VI conference, Lecture Notes in Computer Science No. 1917, Springer, Berlin Heidelberg New York pp 849-858
17. Douglet D, Thoreau E, Grassy G (2000) A genetic algorithm for the automated generation of small organic molecules: Drug design using an evolutionary algorithm. J Comput Aided Mol Des 14:449-466
18. Gellert M (1981) DNA topoisomerases. Ann Rev Biochem 50:879-910
19. Goldberg DE (1989) Genetic algorithms in search, optimization and machine learning. Addison-Wesley, Reading
20. Goldberg DE, Richardson J (1987) Genetic algorithms with sharing for multimodal function optimisation. In: Grefenstette JJ (ed) Proceedings of the second international conference on genetic algorithms. Lawrence Erlbaum, pp 41-49
21. Goldberg DE (2002) The design of innovation: Lessons from and for competent genetic algorithms. Kluwer Dordrecht
22. Haack T, González MJ, Sánchez Y, Giralt E (1997) D-Amino acids in protein de novo design. II. Protein-diastereomerism versus protein-enantiomerism. Lett Pep Sci 4:377-386
23. Holland JH (1975) Adaptation in natural and artificial systems. MIT, Cambridge
24. Jones S, Thornton JM (1997) Analysis of protein-protein interaction sites using surface patches. J Mol Biol 272:121-132
25. Krasnogor N (2002) Studies on the theory and design space of memetic algorithms. PhD Thesis, University of the West England, Bristol
26. Kubinyi H (1999) Chance favors the prepared mind. From serendipity to rational drug design. J Recept Signal Transduct Res 19:15-39
27. Larrañaga P, Lozano JA (2002) Estimation of distribution algorithms. GENA 2. Kluwer, Dordrecht
28. Lebl M (2002) Combinatorial chemistry: The history and the basics. In Mei HY, Czarnik AW. Integrated Drug Discovery Technologies. Marcel Dekker:395-405
29. Lengauer T, Lemmen C, Rarey M, Zimmermann M (2004) Novel technologies for virtual screening. Drug Discov Today 9(1):27-34
30. Loffet A (2002) Peptides as drugs: Is there a market? J Peptide Sci 8:1-7
31. Malmsten M (2002) Surfactants and polymers in drug delivery. Marcel Dekker, New York
32. Mandell A, Selz K, Shlesinger M (2002) Algorithmic design of peptides for binding and/or modulation of the funcions of receptors and/or other proteins.
33. Morris GM, Goodsell DS, Huey R, Hart WE, Halliday S, Belew R, Olson AJ (2003) Userguide Autodock 3.0.5
34. Morris GM, Olson AJ, Goodsel DS (2000) Protein-ligand docking. Methods Princip Med Chem 8:31-48
35. Pegg S, Haresco J, Kuntz I (2001) A genetic algorithm for structure-based de novo design. J Comput Aided Mol Des 15:911-933
36. Pelikan M, Goldberg DE (1999) BOA: The bayesian optimization algorithm. Technical Report 99003, Illinois Genetic Algorithms Laboratory, University of Illinois at Urbana-Champaign
37. Pelikan M, Goldberg DE, Cantú-Paz E (1999) BOA: The bayesian optimization algorithm. In: Proceedings of the genetic and evolutionary computation conference-GECCO 1999. Morgan Kaufmann, San Francisco
38. Pelikan M, Sastry K (2004) Fitness inheritance in the bayesian optimization algorithm. Technical Report 2004009, Illinois Genetic Algorithms Laboratory, University of Illinois at Urbana-Champaign
39. Sastry VH (1995) Strategies for drug design. Eastern Pharmacist 38:455
40. Scheider G, Lee M, Stahl M, Schneider P (2000) De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J Comput Aided Mol Des 14:487-494
41. Seifert MHJ, Wolf K, Vitt D (2003) Virtual high-throughput in silico screening. Biosilico 1(4):143-149
42. Shoichet BK, McGovern SL, Wei B, Irwin JJ (2002) Lead discovery using molecular docking. Curr Opin Chem Biol 6(4):439-446
43. Smith GR, Sternberg MJE (2002) Prediction of protein-protein interactions by docking methods. Curr Opin Struct Biol 12:28-35
44. Thormann M, Pons M (2001) Massive docking of flexible ligands using environmental niches in parallelized genetic algorithms. J Comput Chem 22(16):1971-1982
45. Veselovsky AV, Ivanov AS (2003) Strategy of computer-aided drug design. Curr Drug Targets Infect Disord 3(1):33-40
46. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307-310
47. Wang R, Gao Y, Lai L (2000) Ligbuilder: A multi-purpose pogram for structure-based drug design. J Mol Model 6:498-516
48. Yao X, Liu Y (1997) Fast evolution strategies. In: Peter J. Angeline, Robert G. Reynolds, John R. McDonnell, Russ Eberhart (eds) Evolutionary programming VI. Springer, Berlin Heidelberg New York, pp 151-161
49. Yoshimoto T, Fischl M, Orlowski R, Walter R (1978) Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase. Comparison of two peptidases with high specificity for proline residues. J Biol Chem 253(10):3708-3716
50. Zeng J (2000) Mini-review: Computational structure-based design of inhibitors that target proteins surfaces. Comb Chem High Throughput Screen 3:355-362
51. Zitzler E, Laumanns M, Thiele L (2001) SPEA2: Improving the strength pareto evolutionary algorithm. Technical Report 103, Gloriastrasse 35, CH-8092 Zurich, Switzerland
52. Zou X, Sun Y, Kuntz ID (1999) Inclusion of solvation in ligand binding free energy calculations using the generalized-born model. J Am Chem Soc 121(35):8033-8043